Burden and associated phenotypic characteristics of tuberculosis infection in adult Africans with diabetes: a systematic review.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
14 Nov 2023
14 Nov 2023
Historique:
received:
30
05
2023
accepted:
11
11
2023
medline:
15
11
2023
pubmed:
15
11
2023
entrez:
14
11
2023
Statut:
epublish
Résumé
Diabetes mellitus (DM) increases the risk of developing tuberculosis infection (TBI). However, the evidence on the burden and phenotypic characteristics of TBI in African patients with DM is limited. This study aimed to determine the prevalence and characterisation of TBI in native African patients living with DM. We searched PubMed, EMBASE, and African Journals Online for original studies reporting information on the prevalence and characteristics of TBI in adult Africans with DM. A forest plot was used to describe the pooled prevalence estimate of TBI and the corresponding 95% confidence intervals (CI). Six studies conducted in four African countries involving 721 participants with DM were included in this systematic review. The pooled prevalence estimate of TBI was 40% (95% CI 20-60%, I
Identifiants
pubmed: 37963989
doi: 10.1038/s41598-023-47285-4
pii: 10.1038/s41598-023-47285-4
pmc: PMC10645877
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
19894Subventions
Organisme : European and Developing Countries Clinical Trials Partnership (EDCTP) 2 program supported by the European Union
ID : Grant number RIA2018CO-2514-PROTID
Informations de copyright
© 2023. The Author(s).
Références
Nat Rev Immunol. 2018 Sep;18(9):575-589
pubmed: 29895826
Thorax. 2019 Jan;74(1):91-94
pubmed: 29764958
PLoS Med. 2009 Jul 21;6(7):e1000097
pubmed: 19621072
Fam Pract. 2017 Sep 1;34(5):532-538
pubmed: 28369346
N Engl J Med. 2015 May 28;372(22):2127-35
pubmed: 26017823
Open Forum Infect Dis. 2022 Jun 30;9(7):ofac323
pubmed: 36420425
Trials. 2022 Jun 10;23(1):480
pubmed: 35689272
Lancet Glob Health. 2019 Apr;7(4):e448-e460
pubmed: 30819531
PLoS One. 2017 Apr 21;12(4):e0175925
pubmed: 28430796
Trop Med Int Health. 2022 Apr;27(4):369-386
pubmed: 35146851
Int J Tuberc Lung Dis. 2023 Apr 1;27(4):308-314
pubmed: 37035972
Control Clin Trials. 1986 Sep;7(3):177-88
pubmed: 3802833
BMC Infect Dis. 2019 Mar 13;19(1):254
pubmed: 30866836
J Clin Epidemiol. 2012 Sep;65(9):934-9
pubmed: 22742910
J Infect Dev Ctries. 2022 Apr 30;16(4):644-649
pubmed: 35544626
Trans R Soc Trop Med Hyg. 2017 Feb 1;111(2):81-89
pubmed: 28419376
Clin Infect Dis. 2017 Mar 15;64(6):719-727
pubmed: 27986673
Front Med (Lausanne). 2022 Apr 25;9:899821
pubmed: 35547228
Arch Med Res. 2015 Apr;46(3):221-7
pubmed: 25864989
Chest. 2016 Feb;149(2):516-525
pubmed: 26867835
Lancet. 2010 May 22;375(9728):1814-29
pubmed: 20488524
Curr Diabetes Rev. 2020;16(5):442-449
pubmed: 31657690
J Clin Invest. 2013 Mar;123(3):958-65
pubmed: 23454758